Open Data

In a new study, researchers argue that correlational studies may not sufficiently account for alternative explanations, and offer suggestions for mitigating this danger.

New research shows that more connected and well-known researchers are more likely to be published, even when they receive negative reviews.

Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.

An investigation exposes violations to research ethics, finding that researchers failed to disclose risks and even misled government agencies.

A new analysis of UK mental health data suggests the way organizations deliver mental health services can alter patient outcomes.

New research, based on data from almost a million children in Denmark, suggests that children of mothers who use antidepressants during pregnancy are more likely to be diagnosed with autism and psychiatric disorders.

Correcting unnecessary long-term antidepressant use is difficult and met with apprehension by providers and service-users.

In this piece for FiveThirtyEight, Christie Aschwanden explains how various industries have used the language of the "open science" reform movement, which advocates for more transparency in scientific...

New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.

Scientists at the Yale Collaboration for Research Integrity and Transparency (CRIT) published a new policy paper this month criticizing the current state of biomedical research and calling for improved transparency in research methods.

A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.

New study finds that pharmaceutical industry gifts to medical providers in Washington D.C. are associated with higher cost, higher volume prescribing behavior.

Dr. Madhukar Trivedi and colleagues find that the SSRI sertraline does not reduce depressive symptoms any more than placebo in people with Chronic Kidney Disease.

What does "normal" brain development throughout childhood look like? It may depend on your demographics.

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

Surveyed doctors overestimate pharmacological effects of antidepressants and underestimate placebo effects.

Evidence of duplicate publishing in articles analyzing data from clinical trials testing second-generation antipsychotics for depression

A review of academic textbooks finds that they often leave out effect sizes and molecular genetics findings, both of which suggest minimal impact of genetics on ADHD. Instead, textbooks focus on overblown conclusions from behavioral studies.

Amid calls for a retraction, Lancet Psychiatry publishes articles criticizing the original finding and a response from the authors.

Questionable research practices and poor reproducibility in electrical brain stimulation (EBS) studies.

From The Intercept: Several seemingly independent advocacy groups have recently published advertisements opposing newly proposed legislation that would lower drug prices. In fact, the organizations have undisclosed...

A new study, published in the journal Molecular Psychiatry, found no link between genetics and the occurrence of depressive symptoms.

Meta-analyses including studies that detail these trials could be presenting misleading information.

Study finds more patients are visiting physicians who have ties to industry than previously thought.

An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.